Luisa Hector
Stock Analyst at Berenberg Bank
(3.66)
# 2,157
Out of 4,662 analysts
294
Total ratings
59.1%
Success rate
5.3%
Average return
Main Sectors:
Stocks Rated by Luisa Hector
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRK Merck & Co. | Maintained: Hold | $125 → $127 | $149.81 | -15.23% | 35 | Aug 5, 2026 | |
| ABBV AbbVie | Maintained: Buy | $275 | $264.64 | +3.91% | 19 | Aug 5, 2026 | |
| EPA: SAN Sanofi | Maintained: Buy | €105.00 | €78.67 | +33.47% | 52 | Aug 3, 2026 | |
| LON: AZN AstraZeneca PLC | Maintained: Buy | 16,000p | 12,086p | +32.38% | 71 | Jul 27, 2026 | |
| SWX: ROP Roche Holding AG | Maintained: Hold | CHF 340.00 | CHF 366.30 | -7.18% | 52 | May 8, 2026 | |
| SWX: NOVN Novartis AG | Rated: Hold | CHF 92.00 → CHF 110.00 | CHF 126.94 | -13.34% | 4 | Mar 6, 2026 | |
| LON: BTRW Barratt Redrow plc | Maintained: Hold | 414p | 316p | +30.97% | 1 | Feb 11, 2026 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Buy | kr 400.00 → kr 415.00 | kr 292.26 | +42.00% | 7 | Jan 16, 2026 | |
| LON: GSK GSK plc | Maintained: Hold | 1,660p | 1,920p | -13.54% | 7 | Jan 6, 2026 | |
| SNY Sanofi | Maintained: Buy | $63 → $67 | $45.81 | n/a | 11 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $55 → $60 | $68.03 | n/a | 18 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €197.00 | €139.55 | n/a | 13 | Feb 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $43 | $28.16 | n/a | 1 | Jun 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €77.74 | €49.41 | n/a | 1 | Sep 11, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $14.12 | n/a | 2 | Sep 15, 2016 |
Merck & Co.
Aug 5, 2026
Maintained: Hold
Price Target: $125 → $127
Current: $149.81
Upside: -15.23%
AbbVie
Aug 5, 2026
Maintained: Buy
Price Target: $275
Current: $264.64
Upside: +3.91%
Sanofi
Aug 3, 2026
Maintained: Buy
Price Target: €105.00
Current: €78.67
Upside: +33.47%
AstraZeneca PLC
Jul 27, 2026
Maintained: Buy
Price Target: 16,000p
Current: 12,086p
Upside: +32.38%
Roche Holding AG
May 8, 2026
Maintained: Hold
Price Target: CHF 340.00
Current: CHF 366.30
Upside: -7.18%
Novartis AG
Mar 6, 2026
Rated: Hold
Price Target: CHF 92.00 → CHF 110.00
Current: CHF 126.94
Upside: -13.34%
Barratt Redrow plc
Feb 11, 2026
Maintained: Hold
Price Target: 414p
Current: 316p
Upside: +30.97%
Novo Nordisk A/S
Jan 16, 2026
Maintained: Buy
Price Target: kr 400.00 → kr 415.00
Current: kr 292.26
Upside: +42.00%
GSK plc
Jan 6, 2026
Maintained: Hold
Price Target: 1,660p
Current: 1,920p
Upside: -13.54%
Sanofi
May 16, 2025
Maintained: Buy
Price Target: $63 → $67
Current: $45.81
Upside: n/a
Dec 10, 2024
Maintained: Hold
Price Target: $55 → $60
Current: $68.03
Upside: n/a
Feb 10, 2022
Maintained: Hold
Price Target: €197.00
Current: €139.55
Upside: n/a
Jun 14, 2021
Maintained: Hold
Price Target: $43
Current: $28.16
Upside: n/a
Sep 11, 2018
Maintained: Hold
Price Target: €77.74
Current: €49.41
Upside: n/a
Sep 15, 2016
Reiterated: Hold
Price Target: n/a
Current: $14.12
Upside: n/a